A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects
Clinical trial NCT03906006 · COMPLETED
Trial details
- NCT number
- NCT03906006
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2019-06-20
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.